









Markets
/
Stocks
/
nasdaq-imkta
/

Ingles Markets Inc

IMKTA

68.890USD

-0.390-0.56%

Market hours （ET）Quotes delayed by 15 min

1.31BMarket Cap

23.19P/E TTM



Ingles Markets Inc

68.890

-0.390-0.56%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

14 / 31

Overall Ranking

191 / 4724

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Ingles Markets, Incorporated is a grocer with operations in six southeastern states. The Company, in conjunction with its supermarket operations, operates neighborhood shopping centers, most of which contain an Ingles supermarket. The Company also owns a fluid dairy facility that supplies its supermarkets and unaffiliated customers. Its supermarkets offer customers a variety of nationally advertised food products, including grocery, meat and dairy products, produce, frozen foods and other perishables, and non-food products. Its non-food products include fuel centers, pharmacies, health and beauty care products, and general merchandise. The Company also offers private label items, organic and locally sourced items throughout its market areas. The Company operates a total of approximately 198 supermarkets in North Carolina (75), Georgia (65), South Carolina (35), Tennessee (21), Virginia (1) and Alabama (1). It operates approximately 115 in-store pharmacies and 108 fuel stations.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 11.62%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 11.62%.

Overvalued

The company’s latest PE is 23.32, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 13.66M shares, decreasing 5.78% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.28M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 8.43, which is higher than the Food & Drug Retailing industry's average of 7.09. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.33B, representing a year-over-year decrease of 2.65%, while its net profit experienced a year-over-year decrease of 52.64%.

Score

Industry at a Glance

Previous score

8.43

Change



Financials

8.81

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.75

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.26

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.27

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.08

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 1.80, which is lower than the Food & Drug Retailing industry's average of 2.64. Its current P/E ratio is 22.79, which is -6.09% below the recent high of 21.40 and 16.45% above the recent low of 19.04.

Score

Industry at a Glance

Previous score

4.60

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 14/31

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

There is no earnings forecast score for this company; the Food & Drug Retailing industry's average is 7.38.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 9.16, which is higher than the Food & Drug Retailing industry's average of 7.21. Sideways: Currently, the stock price is trading between the resistance level at 70.96 and the support level at 61.84, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.62

Change

0.16

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.041

Buy

RSI(14)

58.845

Neutral

STOCH(KDJ)(9,3,3)

55.727

Neutral

ATR(14)

1.483

High Vlolatility

CCI(14)

57.308

Neutral

Williams %R

40.456

Buy

TRIX(12,20)

0.347

Sell

StochRSI(14)

40.446

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

69.153

Sell

MA10

69.326

Sell

MA20

67.865

Buy

MA50

66.058

Buy

MA100

64.040

Buy

MA200

64.618

Buy

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Food & Drug Retailing industry's average of 7.38. The latest institutional shareholding proportion is 93.88%, representing a quarter-over-quarter decrease of 0.21%. The largest institutional shareholder is The Vanguard, holding a total of 1.28M shares, representing 8.78% of shares outstanding, with 4.92% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

1.24M

+1.89%

BlackRock Institutional Trust Company, N.A.

1.03M

-0.20%

River Road Asset Management, LLC

975.82K

-0.06%

Dimensional Fund Advisors, L.P.

993.78K

-6.29%

Gabelli Funds, LLC

914.01K

-0.26%

Brandes Investment Partners, L.P.

Star Investors

814.23K

+52.48%

American Century Investment Management, Inc.

514.30K

+8.07%

Charles Schwab Investment Management, Inc.

497.22K

+9.63%

Royce Investment Partners

Star Investors

409.70K

+0.66%

Geode Capital Management, L.L.C.

412.77K

+0.32%

Risk Assessment

Currency: USD Updated：2025-09-12

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The company’s current risk assessment score is 5.98, which is higher than the Food & Drug Retailing industry's average of 4.61. The company's beta value is 0.77. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.